RESEARCH TRIANGLE PARK, NC--(Marketwire - January 28, 2010) - Business intelligence firm
Cutting Edge Information announces the release of its newest study on the
global cancer market, "Oncology Market Forecast to 2015: Brand Spending and
Development Opportunities." A complimentary summary is available for
download at:
http://www.cuttingedgeinfo.com/Oncology/index.htm#body
When CEI first delved into the cancer market, its original oncology
forecasting report ranked in the company's top-seller list for 2009. See
here:
(
http://www.cuttingedgepharma.com/EoQ/December_2009/CEIs_Best.html). The
latest study builds on the analysis, delving into the clinical, commercial,
and regulatory trends affecting oncology therapeutics today -- as well as
their impact in the decade ahead.
CEI's new report details the historical, current and forecasted performance
of 120 drugs treating various forms of cancer and their associated
complications. The report's scope encompasses marketed brands and pipeline
products in clinical development. Factors examined for each drug include
sales projections, market assessments, product longevity, positive or
negative clinical trial results and target patient populations. Besides
highlighting individual drugs, the report analyzes the strengths,
challenges and growth opportunities of each of the top 13 drug makers in
oncology.
A key component in the study is real-world, market-focused expenditures
from the pre-clinical period through the first year on the market, along
with budgeting data from brand directors/managers, marketing team members
and executives from 15 different companies.
"Altogether the profiled brands generated $64 billion in 2009, and oncology
is poised to be the highest-grossing therapeutic area within the next few
years," said Jeremy Spivey, Cutting Edge Information senior analyst. "This
report explores competitive forces and business development possibilities,
and its spending benchmarks will enable teams to develop their budgets."
The report is organized into brand profiles, drug manufacturer profiles and
benchmark data.
Brand Profiles detail a product's historical background, market outlook,
and patent and litigation data. Profiles include the following
information:
-- Drug's current and projected competitive strength
-- Current/projected sales position within its class
-- Sales projection charts for the next four to seven years
-- Assessment of competition
-- Materiality charts
-- Clinical trial information
Company Profiles show breakdowns for 13 companies that have established
cancer franchises or exciting development pipelines. Profiles contain:
-- Oncology ranking
-- Overall industry ranking
-- Strengths analysis
-- Growth areas analysis
-- Competition analysis
-- Key products breakdown
For more information, please visit
http://www.cuttingedgeinfo.com/Oncology/index.htm#body.
Contact Information: MEDIA CONTACT:
Stephanie Swanson
919-433-0212